Firms

Nina Capital

Nina Capital

nina.capital

Barcelona venture capital firm investing at the intersection of healthcare and information technology. It backs pre-seed through seed-stage medical devices and tools for healthcare organizations across Europe, North America, Israel and Australia, with an emphasis on data, computing and founders addressing unmet clinical needs.

Founded
2019
Type
Venture capital

Funds1

  • Nina Capital Fund III—

    Third healthcare technology venture fund, legally NINA CAPITAL FUND III, FCRE. Nina Capital announced its launch on February 12, 2025 with a EUR50 million target. The actual first-close committed amount was not disclosed; EUR50 million is the fundraising target. It backs early-stage companies applying data and technology to clinical innovation, healthcare infrastructure and care pathways across Europe, North America, Israel and Australia. The regulator-published March 2026 prospectus still describes EUR50 million as the target and a EUR15 million minimum first-close threshold, without reporting an achieved final close.

Team

Operations and support

Aline NoizetCommunity Manager
Bob SchulzChief Partnership Officer
Brian NapackBrian NapackInvestment Advisor or Venture Partner (specific role undisclosed)
Fiorela KapllanajSenior Analyst
Gabriel P. KrestinClinical Advisory Board Member
Guillem TorruellaVisiting Analyst
Helen RouthHelen RouthInvestment Advisor or Venture Partner (specific role undisclosed)
Jared TeoJared TeoInvestment Advisor or Venture Partner (specific role undisclosed)
Jordi PedrolHead of Finance
Ken DouglasBoard Member
Kyle SherrillInvestment Manager
Lily ChenLily ChenInvestment Advisor or Venture Partner (specific role undisclosed)
Lisa SerwinLisa SerwinInvestment Advisor or Venture Partner (specific role undisclosed)
Lisa SuennenLisa SuennenInvestment Advisor or Venture Partner (specific role undisclosed)
Lluís Donoso-BachClinical Advisory Board Member
Marc SubiratsGeneral Partner · Board Member
Marta G. ZanchiFounder and Managing Partner · Chairman of the Board
Monica RiveraMonica RiveraInvestment Advisor or Venture Partner (specific role undisclosed)
Natalia Marti PicoSecretary of the Board
Olivia EscuderoVisiting Analyst
Paul YockPaul YockClinical Advisory Board Member
Pietro ScalfaroClinical Advisory Board Member
Rebecca SchechterRebecca SchechterInvestment Advisor or Venture Partner (specific role undisclosed)
Sebastian AnastassiouPartner
Tudor G. JovinClinical Advisory Board Member
Yahel HalamishPartner

Co-investing

Y Combinator
Goodwater Capital
Blumberg Capital
Expeditions
iGan Partners

Investments